Open AccessIs There Any Advantage of Using Polyclonal vs. Monoclonal Antibodies for Passive Enhancement of Immunity in Patients with COVID-19?
Author(s) -
Sohail Rao,
Caitlin White,
Manish Singh
Publication year - 2021
Publication title -
dhr proceedings
Language(s) - English
Resource type - Journals
ISSN - 2689-839X
DOI - 10.47488/dhrp.v1is5.31
Subject(s) - polyclonal antibodies , covid-19 , monoclonal antibody , immunity , virology , monoclonal , antibody , immunology , medicine , immune system , disease , outbreak , infectious disease (medical specialty)